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Abstract  A  longitudinal  study  was  conducted  to  assess  the  presence  of  beliefs  about  symp-
toms related  to  hypertension  and  the  time  since  diagnosis  in  which  they  appear.  A  randomly
selected sample  of  hypertensive  patients  (67%  women,  mean  age  53.27  years  and  range  20-
65) was  divided  into  four  groups  according  to  the  time  from  diagnosis.  All  patients  (N  =  171)
were interviewed  at  the  beginning  (initial  assessment)  and  12  months  later  (ﬁnal  assessment)
and the  patients  (n  =  75)  who  did  not  report  beliefs  about  symptoms  at  the  initial  assessment
were interviewed  in  a  follow-up  schedule.  The  results  showed  that  56%  of  patients  reported
beliefs about  symptoms  at  the  initial  assessment,  and  this  percentage  increased  to  77%  at  the
ﬁnal assessment  (p  <  .001)  ﬁnding  signiﬁcant  differences  between  the  two  groups  with  a  more
recent diagnosis  and  the  two  groups  of  long-standing  patients.  Longitudinal  analysis  of  the  group
with the  recent  diagnosis  showed  that  the  critical  period  for  the  emergence  of  beliefs  was  the
ﬁrst year  from  diagnosis.  This  period  could  be  decisive  in  order  to  prevent  them.  Healthcare
professionals  should  pay  attention  to  the  emergence  of  these  beliefs,  as  they  could  negatively
affect treatment  adherence.
© 2015  Asociación  Espan˜ola  de  Psicología  Conductual.  Published  by  Elsevier  España,  S.L.U.  This
is an  open  access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).PALABRAS  CLAVE Un  estudio  longitudinal  de  las  creencias  sobre  síntomas  en  hipertensión
studio  para  evaluar  creencias  sobre  síntomas  relacionados  con  la
ranscurrido  desde  el  diagnóstico.  Una  muestra  elegida  al  azar  de
 (media  de  edad  53,27  an˜os,  rango  20-65;  67%  mujeres)  se  dividióCreencias;
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síntomas;
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estudio  descriptivo
mediante  encuesta
en  cuatro  grupos  de  acuerdo  al  tiempo  transcurrido  desde  el  diagnóstico.  Se  entrevistó  a  todos
los pacientes  (N  =  171)  al  comienzo  del  estudio  (evaluación  inicial)  y  12  meses  después  (evalu-
ación ﬁnal).  A  los  pacientes  que  no  informaron  creencias  en  síntomas  (n  =  75)  se  les  entrevistó
cada tres  meses  de  acuerdo  a  un  programa  de  seguimiento.  Los  resultados  indicaron  que  en  la
evaluación  inicial  el  56%  de  los  pacientes  informó  creencias  en  síntomas,  elevándose  al  77%  en
la evaluación  ﬁnal  (p  <  .001),  y  diferencias  signiﬁcativas  entre  los  grupos  con  menor  y  mayor
tiempo desde  el  diagnóstico.  El  análisis  longitudinal  del  grupo  de  pacientes  de  reciente  diag-
nóstico mostró  que  el  primer  an˜o  es  el  período  crítico  para  la  emergencia  de  creencias  en
síntomas, información  que  resulta  clave  para  planear  la  prevención.  Los  profesionales  de  la
salud deberían  prestar  atención  a  la  emergencia  de  creencias  en  síntomas  dado  que  pueden
afectar negativamente  a  la  adherencia  al  tratamiento.
© 2015  Asociación  Espan˜ola  de  Psicología  Conductual.  Publicado  por  Elsevier  España,  S.L.U.  Este
es un  artículo  Open  Access  bajo  la  licencia  CC  BY-NC-ND  (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
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mArterial  hypertension  is  one  of  the  main  risk  factors  for
cardiovascular  and  cerebrovascular  events  and  one  of  the
main  causes  of  death  and  disability  in  developed  countries
(Arrebola-Moreno  et  al.,  2014;  Lloyd-Jones  et  al.,  2010;
Sharp,  Aarsland,  Day,  Sønnesyn,  &  Ballard,  2011).  Arterial
hypertension  is  deﬁned  as  values  >140  mmHg  of  systolic
blood  pressure  and/or  >90  mmHg  of  diastolic  blood  pressure
(Mancia  et  al.,  2013).  Although  effective  treatment  is  avail-
able,  a  large  number  of  studies  show  that  treatment  is  poorly
followed  by  hypertensive  patients  (Chobanian,  2009;  Egan,
Zhao,  &  Axon,  2010;  Márquez,  Granados,  &  Roales-Nieto,
2014;  van  Onzenoort  et  al.,  2010).  Many  factors  related
to  patients’  beliefs  and  perceptions  about  the  illness  and
its  treatment  have  been  explored  as  variables  related  to
poor  treatment  adherence  (AlGhurair,  Hughes,  Simpson,  &
Guirguis,  2012;  Alhalaiqa,  Deane,  Nawaﬂeh,  Clark,  &  Gray,
2012;  AlHewiti,  2014;  Marshall,  Wolfe,  &  McKevitt,  2012;
Rajpura  &  Nayak,  2013,  2014;  Ross,  Walker,  &  McLeod,  2004;
Ruppar,  Dobbels,  &  De  Geest,  2012).
Even  though  hypertension  is  considered  an  asymptomatic
condition,  several  studies  have  been  oriented  to  explore
patients’  beliefs  about  hypertension  since  the  seventies.
The  association  of  symptoms  with  hypertension  has  been
explored  in  several  studies.  Some  studies  (Baumann  &
Leventhal,  1985;  Brondolo,  Raymond,  Rosen,  John,  &  Kostis,
1999;  Kottke,  Tuomilehto,  Puska,  &  Salome,  1979)  have
not  found  any  relationship  between  symptoms  reported  and
blood  pressure  (BP),  arguing  that  hypertension  has  no  spe-
ciﬁc  symptoms  that  could  be  useful  to  the  patient  for  an
estimation  of  his/her  blood  pressure.  As  well,  some  studies
(Baumann  &  Leventhal,  1985;  Brondolo  et  al.,  1999;  Kottke
et  al.,  1979)  have  not  found  any  signiﬁcant  relationship
between  reported  symptoms,  mood  states  and  ﬂuctuations
in  systolic  pressure.
Other  studies  (Kruszewski,  Bieniaszewski,  &  Krupa-
Wojciechowska,  2000;  Meyer,  Leventhal,  &  Gutman,  1985)
have  found  that  a  high  percentage  of  hypertensive  patients
reported  symptoms  which  they  believed  that  were  associ-
ated  to  high  blood  pressure  and,  consequently,  they  used
them  to  estimate  their  blood  pressure  and  to  make  decisions
about  the  treatment  followed.  This  pattern  of  behaviour  can
be  considered  as  beliefs  about  false  symptoms  that  could
O
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snterfere  with  treatment,  that  is,  it  would  be  a  mistaken
eneralization  of  what  Leventhal  and  his  associates  called
‘common  sense  use  of  symptoms’’  as  indicators  of  disease
Meyer  et  al.,  1985).  Studies  that  have  explored  the  pres-
nce  of  these  beliefs  in  hypertensive  patients  and  their  role
n  estimating  blood  pressure  show  that  the  percentage  of
atients  who  use  symptoms  to  estimate  their  blood  pres-
ure  varies  from  50%  to  92%  (Cantillon  et  al.,  1997;  Kjellgren
t  al.,  1998).
Beliefs  about  symptoms  associated  with  hypertension  can
egatively  affect  adherence  to  treatment,  as  several  studies
ave  shown  (Alison,  Leventhal,  &  Leventhal,  2013;  Cantillon
t  al.,  1997;  Granados  &  Gil  Roales-Nieto,  2005,  2007;
ranados,  Roales-Nieto,  Moreno,  &  Ybarra,  2007;  Kjellgren
t  al.,  1998;  Marshall  et  al.,  2012;  Ross  et  al.,  2004)  and
nowledge  of  the  variables  associated  with  their  devel-
pment  and  maintenance  could  be  of  interest  to  improve
dherence.  Most  patients  showing  this  type  of  beliefs  inter-
ret  the  perception  of  symptoms  as  a  sign  that  their  BP
s  high,  which  could  have  the  risk  of  changing  their  treat-
ent  themselves.  And  vice  versa,  they  interpret  the  absence
f  symptoms  as  a  sign  that  their  BP  is  controlled.  For
xample,  in  a  study  with  163  hypertensive  patients  with
harmacological  treatment,  we  found  that  55.5%  of  the
atients  with  beliefs  about  symptoms  reported  failures  in
heir  treatment  adherence,  while  this  only  happened  in
5.7%  of  the  patients  that  did  not  report  beliefs  about  symp-
oms  (Granados  et  al.,  2007).  This  relationship  between
on-adherence  to  treatment  and  symptom  beliefs  was  sta-
istically  signiﬁcant  (2 =  9.74,  p  <  .01;  CI  95%  =  1.56  -  8.28),
ith  a  relative  risk  of  2.15  (CI  95%  =  1.20  -  3.86)  that  the
resence  of  beliefs  was  associated  with  failures  in  treatment
dherence.
Also,  a  recent  study  has  shown  that  the  modiﬁcation  of
eliefs  about  false  symptoms,  using  a  feedback  procedure,
rought  an  improvement  on  treatment  adherence  (Roales-
ieto,  Granados,  &  Márquez,  2014).
Nonetheless,  the  emergence  of  these  beliefs  and  their
aintenance  over  time  has  not  been  sufﬁciently  explored.
nly  one  study  provided  longitudinal  data,  reporting  that
1%  of  65  newly  treated  hypertensive  patients  already
howed  beliefs  about  symptoms  (e.g.,  headache,  feeling
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heir  face  burning,  or  their  heart  pounding)  at  the  beginning
f  treatment,  while  in  a  six-month  follow-up,  the  number  of
atients  who  reported  beliefs  had  risen  to  92%.  However,
he  time  since  each  patient  was  diagnosed  as  hypertensive
as  not  considered  (Meyer  et  al.,  1985).
To  the  best  of  the  authors’  knowledge,  no  prior  research
xists  that  directly  addresses  the  objectives  of  the  present
tudy.  The  main  purpose  of  this  study  was  to  explore,  in  a
ongitudinal  design,  the  presence  of  beliefs  about  symptoms
n  a  sample  of  hypertensive  patients,  and  the  relationship
etween  time  since  diagnosis  and  the  report  of  beliefs  about
ymptoms.  Information  related  to  the  moment  in  which
hese  beliefs  emerge  could  be  useful  for  health-care  teams
ttending  patients  with  hypertension.
ethod
esign  and  participants
 descriptive  survey  study  according  to  the  classiﬁcation
f  Montero  and  León  (2007)  involving  patients  with  hyper-
ension  who  were  receiving  regular  medical  care  in  one
rimary  Care  Centre  in  the  city  of  Almería  (Spain).  Eligible
atients  could  not  be  over  65  years  old  or  under  18.  Patients
ith  other  disorders  (e.g.,  diabetes,  asthma,  cardiovascular
isease  and  dyslipidaemias)  or  a  diagnosis  of  mental  disor-
er  (e.g.,  depression,  anxiety  disorder)  were  excluded.  The
tudy  sample  was  selected  from  among  the  total  group  of
atients  with  diagnosis  of  hypertension  (342)  stratiﬁed  by
ime  since  diagnosis  of  hypertension.  The  ﬁnal  sample  was
omposed  of  171  eligible  patients  that  accepted  to  partici-
ate,  33  eligible  patients  refused  to  participate.  All  patients
ere  informed  that  the  purpose  of  the  study  was  to  ‘‘get  a
etter  understanding  of  the  experiences  of  patients  with  the
isease’’.
The  study  was  approved  by  the  Ethics  Committee  of  the
niversity  of  Almeria  and  the  Research  Committee  of  the
ealth  District  of  Almeria.  Informed  Consent  by  each  par-
icipant  was  obtained.  Participants  were  told  that  the  data
ould  be  treated  in  a  manner  that  respected  the  conﬁden-
iality  and  the  anonymity.
rocedure
articipants  were  distributed  in  four  groups  according  to
ime  since  diagnosis:  Group  1  (G1)  patients  with  a  recent
iagnosis  (in  the  previous  3  months);  Group  2  (G2)  patients
ho  had  been  diagnosed  in  the  previous  4  to  12  months;
roup  3 (G3)  patients  who  had  been  diagnosed  between
3  months  and  2  years  before;  and  Group  4  (G4)  patients
iagnosed  over  two  years  before.
A  longitudinal  study  was  conducted  by  way  of  interviews
ith  patients  over  time  to  evaluate  the  presence  of  beliefs
bout  symptoms.  The  initial  and  ﬁnal  reports  of  beliefs  in  the
otal  sample  were  evaluated  at  two  different  stages:  at  the
eginning  of  the  study  (Initial  assessment)  and  the  other  one
2  months  later  (Final  assessment).  Belief  in  symptoms  asso-
iated  with  high  blood  pressure  was  deﬁned  as  the  report
nd  identiﬁcation  of  symptoms  that  the  patient  believes  are
ssociated  to  his/her  high  blood  pressure.
p
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The  procedure  was  implemented  according  to  a  three-
tage  protocol  (see  Figure  1).  In  the  ﬁrst  stage,  patients  were
sked  about  their  blood  pressure  with  the  general  question
y  Meyer  et  al.  (1985):  ‘‘Do  you  think  you  can  tell  when
our  blood  pressure  is  up?’’.  If  the  answer  was  negative,
he  patient  was  classiﬁed  as  ‘‘non-symptomatic’’,  and  no
ore  questions  were  asked  about  this.  In  the  second  stage,
he  patients  who  had  given  a  positive  answer  to  the  gen-
ral  question  were  asked:  ‘‘How  do  you  know  if  your  BP
s  high?’’.  If  the  answer  was  not  related  with  symptoms
e.g.,  ‘‘Because  I  measure  it’’),  the  patient  was  classiﬁed  as
‘non-symptomatic’’  and  no  more  questions  about  it  were
sked.  The  third  stage  was  only  carried  out  with  patients
ho  considered  their  blood  pressure  to  be  high  because
hey  had  perceived  some  symptoms  (patients  classiﬁed  as
‘symptomatic’’).  In  these  cases,  new  questions  were  added
bout  their  symptoms  (i.e.,  type,  frequency,  intensity.  .  .).
Patients  who  did  not  report  beliefs  about  symptoms  at  the
nitial  Assessment  were  interviewed  again  during  a  follow-up
eriod  (usually  every  three  months  when  they  came  to  the
cheduled  visits  to  the  general  practitioner).  Those  patients
ho  reported  symptoms  any  time  during  the  follow  up  were
lassiﬁed  as  ‘‘symptomatic’’  according  to  the  third  stage  of
he  study  protocol.
All  patients  were  evaluated  at  the  Final  Assessment.
We  contacted  with  all  patients  with  a  diagnosis  of  hyper-
ension  assigned  to  the  Can˜ada  de  San  Urbano  Primary  Care
entre  (Almeria,  Spain).  Participants  were  patients  that
ccepted  to  take  part  of  the  study  and  met  the  two  criteria
f  eligibility.  The  ﬁrst  author,  who  was  not  the  treating  physi-
ian  neither  the  attending  nurse,  informed  the  participants
bout  the  aim  of  the  study.
ata  analysis
ualitative  variables  were  described  as  number  and  per-
entage.  Quantitative  variables  were  described  as  mean  and
tandard  deviation.  Statistical  differences  on  age  between
atients  that  reported  symptoms  and  those  who  did  not  were
valuated  using  Student  test,  and  statistical  differences
n  sex  were  evaluated  using  Chi-square  test.  A  univariate
nalysis  was  carried  out  using  a  Chi-square  test  to  detect
igniﬁcant  differences  in  the  percentage  of  patients  who
eported  symptoms,  both  in  the  initial  and  ﬁnal  assessments.
he  McNemar  Test  was  used  for  intra-group  comparisons.
e  considered  a  level  of  statistical  signiﬁcance  of  .05  (p
alue).  Analyses  were  carried  out  using  the  program  SPSS
9.0  (Mac-iOS  version).
esults
he  sample  was  composed  of  171  patients  with  hyper-
ension,  67%  women,  with  a  mean  age  of  53.27  years
SD  =  10.65),  and  ranging  from  20  to  65.  All  patients  were
reated  with  antihypertensive  drugs.  The  main  characteris-
ics  of  the  sample  as  well  as  its  distribution  over  time  since
iagnosis  are  summarized  in  Table  1.The  results  showed  that  in  the  Initial  Assessment,  96
atients  out  of  171  (56%)  were  classiﬁed  as  symptomatic,
s  they  reported  to  be  able  to  know  when  their  BP  was
igh  because  of  the  presence  of  symptoms.  The  rest  of  the
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171 patients with hypertension diagnosis and treatment
G1: 27 patients with
diagnosis less than 3
months ago
G2: 43 patients with
diagnosis 4-12
months ago
Initial
assessment
No
(Non symptomatic patients) Yes
First
stage
Second
stage
Third
stage
Questions about
symptoms
Yes
(to second stage)
No
(F-U)
12 months
Follow-Up
3m
6m
9m
Final assessment
Generic question to all patients
Answers not related
with symptoms
(non symptomatic patients)
Answers related
 with symptoms
(symptomatic patients)
Specific question: How do you
know when your blood
pressure is up?
Generic question: Do you think you can tell when your
blood pressure is up?
G3: 32 patients with
diagnosis 1-2
years ago
G4: 69 patients with
diagnosis more than
2 years ago
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GFigure  1  Tree-stage  protocol  with  the  Initial  and  Fi
sample,  75  patients  (44%),  reported  not  to  know  the  state
of  their  BP  and  were  classiﬁed  as  non-symptomatic. There
were  no  signiﬁcant  differences  between  belief  in  symptoms
and  age  and  gender  of  the  patients.  In  the  Final  assess-
ment,  the  number  of  patients  classiﬁed  as  symptomatic
rose  to  132  (77%),  as  during  the  follow-up  period  36  more
patients  reported  being  able  to  know  when  their  BP  was
high  due  to  the  presence  of  symptoms.  All  patients  classi-
ﬁed  as  symptomatic  in  any  of  the  previous  assessments  were
also  classiﬁed  as  symptomatic  in  the  Final  assessment.  Sig-
niﬁcant  differences  in  the  number  of  symptomatic  patients
between  the  Initial  and  Final  assessments  were  found  (p  <
.001).  The  main  symptoms  reported  by  patients  included
headache  (reported  by  88%  of  symptomatic  patients),  dizzi-
ness  (57%),  nervousness  (52%),  tachycardia  (15%),  and
rubefaction  (11%).  All  patients  reported  more  than  one
symptom.
The  analysis  of  the  results  according  to  time  since
diagnosis  shows  important  differences.  Figure  2  shows  the
percentages  of  symptomatic  patients  in  the  Initial  and
Final  assessments  for  the  different  groups.  The  biggest
changes  are  found  in  G1  and  G2,  those  with  a  shorter
time  period  since  diagnosis.  In  G1  only  22%  of  the  patients
were  classiﬁed  as  symptomatic  in  the  Initial  assessment,
m
F
p
sssessment  of  beliefs  about  symptoms  related  to  HBP.
ut  this  ﬁgure  increases  to  78%  in  the  Final  assessment,
ith  signiﬁcant  differences  (p  <  .001).  In  G2  the  initial
ercentage  of  symptomatic  patients  was  33%,  increasing
o  67%  in  the  Final  assessment,  also  displaying  statistically
igniﬁcant  differences  (p  <  .01).  In  groups  G3  and  G4  those
ith  a  longer  time  period  since  diagnosis,  the  changes  were
uch  smaller  and  no  statistical  signiﬁcance  was  found.
Between-group  comparisons  of  the  Initial  assessment
see  Table  2  and  Figure  2)  indicated  signiﬁcant  differences
etween  G1  and  G3  (p  <  .01),  and  between  G1  and  G4  (p
 .01),  but  not  among  G1  and  G2  (p  =  .62).  Also,  signiﬁcant
ifferences  were  found  between  G2  and  G3  (p  <  .05),  and
etween  G2  and  G4  (p  <  .01).  In  the  Final  assessment,  no
roup  showed  signiﬁcant  differences  in  comparison  with  the
thers.  In  summary,  most  of  the  patients  reported  beliefs
bout  symptoms  at  the  ﬁnal  assessment.
In  order  to  obtain  information  related  to  the  moment  at
hich  beliefs  about  symptoms  appear,  a  longitudinal  analysis
f  symptomatic  patient  percentages  was  carried  out  only  for
1  and  G2,  using  the  Initial,  3  months  follow-up  (FU-3m),  6
onths  follow-up  (FU-6m),  9  months  follow-up  (FU-9m)  and
inal  assessments.  Figure  3  shows  the  development  of  the
ercentage  of  symptomatic  patients  in  G1  and  G2.  A  progres-
ive  increase  in  the  percentage  of  symptomatic  patients  was
204  G.  Granados-Gámez  et  al.
Table  1  Patients’  characteristics.
Symptomatic
patients  (SP)  at
Initial  assessment
Nonsymptomatic
patients  (NSP)  at
Initial  assessment
p  value
SP/v/NSP
N  171  96  (56%)  75  (44%)
Men n  (%)  57  (33.3%)  24  33
.008
Women n  (%)  114  (66.7%)  72  42
Age mean  years  (SD)  53.27  (10.65)  53.45  (10.648)  53.10  (10.579) .414
Age range  (years)  Total  sample  20-65  20-65  22-65
Age mean  years  (SD)  for  women  53.53  (9.97)  53.55  (10.305)  53.67  (9.509)
Age mean  years  (SD)  for  men 52.67  (11.92) 53.18  (11.792) 52.41  (11.908)
Time from
diagnosis  n  (%)
- Less  than  3  months  (G1) 27  6  (22%) 21  (78%)
- Between  4-12  months  (G2) 43  14  (33%) 29  (67%)
- Between  1-2  years  (G3)  32  23  (72%)  9  (28%)
- More  than  2  years  (G4)  69  53  (77%)  16  (23%)
Medication  n  (%)
ACEI  56  (33%)  29  27
.734
Diuretics 25  (15%)  16  9
AIIRA 72  (42%)  42  30
Other  18  (10%)  9  9
BP values Average  (SD)  DBP  85  (11.649)  83  (12.688)  .624
Average (SD)  SBP  142  (14.913)  138  (16.560)  .106
Smoking n  (%)  3  (3%)  6  (8%)
Symptom beliefs
reported  at  Initial
Assessment:
Headache  84  (88%)  -
Dizziness  55  (57%)  -
Nervousness  50  (52%)  -
Number of  patients
reporting  (%  of  SP)
Tachycardia  14  (15%)  -
Rubefaction 11  (11%)  -
Others  15  (16%)  -
G1***
0%
22% 22%
33%
72% 77%
78%
67%
81% 81%78%
33%
67% 72%
77% 81%81%
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100%
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Initial assessment
Intra-group comparisons
Pe
rc
e
n
ta
ge
 o
f s
ym
to
m
at
ics
pa
tie
nt
s
Pe
rc
e
n
ta
ge
 o
f s
ym
to
m
at
ics
pa
tie
nt
s
Between groups comparisons
Final assessment
Final assessment
F  of  s
( ets:  n
o
6
a
I
b
s
o
t
D
T
g
C
a
b
t
b
d
s
m
c
pigure  2  Intra  and  between  group  comparisons  in  percentage
Notes: McNemar  test  ***=  p  <  .001;  **=  p  <  .01.  Between  brack
bserved  in  G1,  going  from  22%  at  the  Initial  assessment,  to
6%  at  the  follow-up  (FU-6m),  and  reaching  78%  in  the  Final
ssessment.  There  were  signiﬁcant  differences  between  the
nitial  and  FU-3m  (p  <  .05)  and  FU-6m  assessments  (p  <  .001),
ut  not  between  the  FU-6m  and  Final  assessments.  G2  also
howed  a  change  in  the  percentage  of  symptomatic  patients
ver  time.  There  were  signiﬁcant  differences  only  between
he  Initial  and  FU-3m  assessments  (p  <  .05).iscussion
his  study  presents  a  longitudinal  analysis  of  the  emer-
ence  of  beliefs  about  symptoms  related  to  blood  pressure.
m
d
Kymptomatic  patients  at  Initial  and  Final  Assessments.
umber  of  symptomatic  patients  in  each  group).
ompared  to  previous  studies  it  is  innovative  as  it
llows  the  moment  at  which  these  beliefs  appear  to
e  ascertained.  The  patients  were  classiﬁed  as  symp-
omatic  or  non-symptomatic  based  on  their  reports  of
eliefs  about  symptoms  (mainly  headache,  nervousness,
izziness,  and  rubefaction).  Those  patients  who  were  clas-
iﬁed  as  non-symptomatic  were  evaluated  every  three
onths  over  a  total  period  of  one  year.  The  results  indi-
ate  that  new  symptomatic  patients  emerged  and  the
ercentage  of  symptomatic  patients  rose  during  the  study,
ainly  in  groups  1 and  2  (those  with  a  more  recent
iagnosis).
The  results  are  consistent  with  previous  studies  (e.g.,
jellgren  et  al.,  1998;  Kruszewski  et  al.,  2000)  indicating
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Table  2  Between-groups  comparisons  for  Initial  and  Final  assessments.
Comparisons  Initial  assessment  Comparisons  Final  assessment
Group  2  Group  3  Group  4  Group  2  Group  3  Group  4
Group  1  p=  .62  p  <  .01  p  <  .01  p  =  .35  p  =  .74  p  =  .70
Group 2  p  <  .05  p  <  .01  p  =  .18  p  =  .09
Group 3  p  =  .59  p  =  .99
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tthe  importance  of  this  phenomenon,  one  which  affects  a
high  percentage  of  hypertensive  patients  that  believe  they
are  able  to  estimate  their  BP  level  based  on  certain  signs
that  they  consider  to  be  indicative  symptoms  of  high  blood
pressure.  This  gives  said  patients  a  false  sense  of  control
which  could  negatively  affect  their  treatment  adherence
(Cantillon  et  al.,  1997;  Granados  &  Gil  Roales-Nieto,  2005,
2007;  Granados  et  al.,  2007;  Kjellgren  et  al.,  1998),  espe-
cially  as  other  studies  have  found  that  symptomatic  patients
establish  a  conﬂicting  generalization,  i.e.  ‘‘the  absence  of
symptoms  means  that  the  BP  is  normal’’,  irrespective  of
their  adherence  to  treatment  (Granados  &  Roales-Nieto,
2005,  2007).
Our  results  indicate  that  time  elapsed  since  diagnosis
could  be  a  very  important  variable  in  the  formation  of  beliefs
about  symptoms,  as  it  is  shown  by  the  progressive  increase
in  the  percentage  of  symptomatic  patients  as  time  passes
after  diagnosis.
The  results  of  the  Initial  assessment  already  show  a
pattern  between  the  groups  in  the  reporting  of  symptoms
according  to  time  since  diagnosis,  conﬁrming  that  a  longer
history  of  hypertension  is  related  to  a  higher  probability  of
belief  in  symptoms.  The  percentage  of  symptomatic  patients
in  the  initial  assessment  is  signiﬁcantly  less  in  the  groups
with  a  shorter  time  since  diagnosis  (G1  and  G2),  and  the
bigger  the  difference  in  time  since  diagnosis,  the  bigger  the
differences  between  the  groups  in  relation  to  the  presence
of  symptoms.
100%
80%
60%
22%
37%
66%
Initial assessment FU3m FU6m FU9m Final assessment
74% 78%
33%
56% 60%
63% 67%
40%
20%
0%
G1 G2
Figure  3  Evolution  of  the  percentage  of  symptomatic  patients
throughout  assessments.  Note:  FU6m,  FU3m  and  FU9m  percent-
ages  were  calculated  from  the  total  number  of  patients  in  each
group, including  as  symptomatic  the  ones  that  were  classiﬁed  as
such in  the  previous  assessments  and  the  patients  that  emerge
as symptomatic  in  that  speciﬁc  follow-up  assessment.
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rParticularly,  an  analysis  of  G1  allows  to  establish  that  the
rst  year  since  diagnosis  is  a  critical  time  period  for  the
mergence  of  beliefs  about  symptoms.  Data  from  groups  3
nd  4  (those  with  a  longer  time  since  diagnosis)  indirectly
onﬁrm  the  idea  that  the  majority  of  patients  that  generate
ymptoms  beliefs  do  it  during  the  ﬁrst  months  since  diagno-
is,  as  in  these  groups  very  few  symptomatic  patients  appear
uring  the  follow  up  period.  In  fact,  the  total  percentage
f  symptomatic  patients  shown  at  the  end  of  the  study  in
roups  1  and  2  is  similar  to  that  of  groups  3  and  4  at  the
eginning  of  the  study,  and  the  time  passed  since  diagnosis
n  groups  1  and  2  at  the  end  of  the  study  is  the  same  as  group
 at  the  beginning.  This  could  indicate  that  after  one  year
ince  diagnosis,  the  emergence  of  beliefs  about  symptoms
s  almost  incidental.  Therefore,  the  ﬁrst  year  since  diagno-
is  seems  to  be  a  critical  period  for  the  emergence  of  new
ases  of  symptomatic  patients,  as  during  this  period  nearly
ll  patients  who  come  to  generate  beliefs  about  symptoms
merge.
The  reasons  why  the  majority  of  symptomatic  patients
merge  during  this  critical  period  are  not  clear,  and  stud-
es  that  analysed  this  phenomenon  would  be  needed.  In
ny  case,  the  association  of  symptoms  to  pathological  pro-
esses  is  a  common  and  natural  human  experience,  so
hat  for  a  patient  it  could  be  ‘‘natural’’  or  ‘‘logic’’  to
elieve  that  their  pathological  state  (being  diagnosed  as
ypertensive)  is  associated  with  signs  of  that  condition
symptoms).  According  to  the  hypothesis  of  the  ‘‘common
ense’’  use  of  symptoms  as  indicators  of  disease,  people
re  likely  to  assume  that  they  can  detect  illness  by  mon-
toring  body  symptoms  and  to  use  symptoms  to  guide  and
valuate  their  body  state  (Leventhal,  Nerenz,  &  Steele,
984).  As  Baumann  and  Leventhal  (1985)  established  this
‘common  sense’’  use  of  symptoms  as  indicators  of  disease,
t  is  most  probably  the  product  of  a history  of  acute  illness
pisodes  throughout  their  life  and  the  corresponding  social
earning.  The  presence  of  symptoms  usually  accompanied
edical  visits,  diagnoses,  prescriptions,  and  social  relation-
hips  with  other  people  about  one’s  and  other’s  physical
tates.  These  experiences  produce  a  set  of  learned  illness
rototypes  or  schemata  about  the  occurrence  of  a  symptom
nd  the  effect  of  the  verbal  label  ‘‘hypertensive’’  meaning
‘I’m  ill.’’
When  considering  these  results,  the  methodological  con-
itions  of  the  study  should  be  taken  into  account.  Firstly,
atients  responded  to  open  questions  in  the  context  of  a
tructured  interview,  without  help  or  guidance,  which  could
ave  led  them  to  form  beliefs  related  to  hypertension.  This
ets  the  study  apart  from  previous  ones  in  which  patients
esponded  to  surveys,  questionnaires  or  checklists  which
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sked  about  the  occurrence  and  intensity  of  speciﬁc  symp-
oms,  without  controlling  the  possible  effects  of  suggestion
r  considering  that  the  patients  could  have  subsequently
erived  a  possible  ‘‘relationship’’  between  symptoms  and
lood  pressure  (Brondolo  et  al.,  1999;  Cantillon  et  al.,  1997;
jellgren  et  al.,  1998;  Meyer  et  al.,  1985).  Secondly,  the
articipants  in  this  study  represent  a  large  amount  of  the
otal  number  of  hypertensive  patients  in  the  area  where  the
tudy  took  place,  and  as  such,  it  may  be  able  to  represent  the
eterogeneity  of  that  population.  However,  the  ﬁnal  compo-
ition  of  some  groups  had  reduced  number  of  participants,
hich  could  be  a  limitation  for  the  generalization  of  the
esults,  and  is  an  aspect  which  requires  further  studies  with
arger  samples.
Another  possible  limitation  of  the  study  is  the  dispar-
ty  in  numbers  of  male  and  female  participants.  However,
his  is  a  frequent  occurrence  in  studies  with  hypertensive
atients  and  the  analyses  indicate  that  no  signiﬁcant  dif-
erences  were  found  related  to  the  reporting  of  symptoms
ccording  to  gender.
The  results  of  our  study  allow  some  important  conclusions
elated  to  the  treatment  of  hypertension  in  Primary  Health
are  service  to  be  drawn.  Firstly,  the  majority  of  patients
ho  participated  in  the  study  reported  beliefs  in  the  form
f  false  symptoms  related  to  high  BP,  and  as  such,  we  are
ealing  with  a  phenomenon  which  affects  a  signiﬁcant  per-
entage  of  patients  and  requires  the  necessary  attention  in
reatment  protocols  and  monitoring.  Currently,  these  beliefs
re  neither  evaluated  nor  considered  in  treatment  proto-
ols,  even  though  the  data  clearly  show  their  importance  as
 risk  factor  for  adherence  (e.g.,  Aroian,  Peters,  Rudner,  &
ase,  2012;  Cantillon  et  al.,  1997;  Chen,  Tsai,  &  Chou,  2011;
ranados  &  Gil  Roales-Nieto,  2005,  2007;  Granados  et  al.,
007;  Kjellgren  et  al.,  1998).
Secondly,  the  results  indicate  that  the  passing  of  time
s  a  very  important  aspect,  with  a  critical  period  for  the
mergence  of  these  beliefs.  As  such,  new  studies  to  inves-
igate  whether  preventive  action  during  the  ﬁrst  year  could
top  or  reduce  the  formation  of  these  beliefs  are  vital.  Any
ype  of  preventive  intervention  with  the  aim  of  avoiding  the
ormation  of  these  beliefs  and  preventing  them  from  becom-
ng  risk  factors  in  treatment  adherence  should  take  these
ata  into  account  and  be  conducted  within  one  year  from
iagnosis.
Finally,  in  their  short  but  intense  review  of  the  role  of
erceptions  and  behaviour  of  hypertensive  patients,  the
onclusion  stated  by  Langman,  Lyons,  and  Lip  (2001)  that
‘comprehensive  investigation  of  the  behaviour  types  of
atients,  and  types  of  perceptions  patients  hold  about  their
llness  and  treatment  is  required’’  gains  importance  with  the
esults  of  this  study,  indicating  that  the  patient’s  behaviour
an  be  a  relevant  factor  in  hypertension  care  and  should  be
eeply  explored.
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